Exosome-Based Multivalent Vaccine: Achieving Potent Immunization, Broadened Reactivity, and Strong T-Cell Responses with Nanograms of Proteins
Mafalda Cacciottolo(Capricor Therapeutics (United States)), Minghao Sun(Capricor Therapeutics (United States))
Cited by 38
Related Papers
Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental models
|Translational Psychiatry|2017|435
Nanograms of SARS-CoV-2 spike protein delivered by exosomes induce potent neutralization of both delta and omicron variants
|PLoS ONE|2023|14
Nanograms of SARS-CoV-2 Spike Protein Delivered by Exosomes Induce Potent Neutralization of Both Delta and Omicron Variants
|bioRxiv (Cold Spring Harbor Laboratory)|2023|7
Exosome based multivalent vaccine: achieving potent immunization, broadened reactivity, and strong T cell responses with nanograms of proteins
|bioRxiv (Cold Spring Harbor Laboratory)|2023|2
Multivalent Exosome based protein vaccine: a “mix and match” approach to epidemic viruses’ challenges
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0